Send us a text

Pharmaceutical giant Novartis invested billions in Slovenia, helping turn the country into a global player in generic drug production.  Now, as cheap Asian competitors increasingly dominate the market, Swiss drug companies see the tiny Balkan nation playing a key role in their shift to more complex, expensive medicines.

Articles and videos on Switzerland's investment in Slovenia are available on swissinfo.ch. For other science stories from Switzerland please go to www.swissinfo.ch/science.

Journalist: Jessica Davis Plüss
Host: Jo Fahy
Audio editor/video journalist: Céline Stegmüller & Michele Andina
Distribution and Marketing: Xin Zhang

SWI swissinfo.ch is a public service media company based in Bern, Switzerland.